Cite
MLA Citation
C. Ryan et al.. “P674: UPDATED RESULTS OF A PHASE 1B STUDY OF IBRUTINIB (IBR) PLUS OBINUTUZUMAB (OBIN) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL).” HemaSphere, vol. 6, n.d., pp. 572–573. http://access.bl.uk/ark:/81055/vdc_100159756159.0x000009